SOURCE: Infor

Infor

SOURCE: Recipharm

Recipharm

July 08, 2015 09:00 ET

Recipharm Reduces Risk and Improves Compliance With Infor

NEW YORK, NY--(Marketwired - July 08, 2015) - Recipharm today announces that it has deployed Infor M3 from Infor, the industry cloud company. Infor Enterprise Resource Planning (ERP) application will help reduce risk by enabling standard processes across all Recipharm manufacturing facilities in Sweden. Infor M3 will also help Recipharm continue to improve compliance with the European Union's GMP (EU-GMP) code of practice.

Following a period of organic and acquisitive growth, Recipharm sought to streamline its ERP system as part of a strategy to reduce the risks presented by a fragmented suite of legacy applications. Following a lengthy selection process, Infor M3 was chosen as it needed fewer customizations, was quicker to implement and offered a lower total cost of ownership.

The application was implemented by Infor partner Merit Globe. The project included integration with third party systems as well as a migration from IBM AS/400 to Microsoft SQL.

"Infor M3 is inherently less complex than comparable systems, and we were impressed by Infor's substantial investment in the application," said Mikael Porat, director of supply chain, Recipharm. "We can see that new features are being developed and industry-specific functionality added, removing the need for customization. This is critical for us as we instigate business process improvement projects. Looking ahead we are assessing options outside of the ERP such as electronic signature (ES), as this is of major importance for compliance within the pharmaceutical industry."

"Success in the pharmaceutical industry depends on managing two contrasting factors, continual product innovation and complete compliance with regulations," said Mark Humphlett, director, Industry and Solution Strategy, Infor. "From an operational perspective this means an agile ERP and standardized processes are critical. Customizations must be kept to a minimum and integration must be lightweight and flexible to support growth. Through implementing Infor M3 throughout its operations, Recipharm can have confidence that both of these driving forces are being supported."

For more information, please visit www.recipharm.com.

About Recipharm

Recipharm is a leading CDMO (Contract Development and Manufacturing Organisation) in the pharmaceutical industry employing some 2,200 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material including API and pharmaceutical product development. Recipharm manufactures more than 400 different products to customers ranging from Big Pharma to smaller research and development companies. Recipharm's turnover is approximately SEK 3.3 billion and the Company operates development and manufacturing facilities in Sweden, France, the UK, Germany, Spain, Italy and Portugal and is headquartered in Jordbro, Sweden. The Recipharm B-share (RECI B) is listed on NASDAQ Stockholm.

For more information on Recipharm and our services, please visit www.recipharm.com

About Infor

Infor is fundamentally changing the way information is published and consumed in the enterprise, helping 73,000 customers in more than 200 countries and territories improve operations, drive growth, and quickly adapt to changes in business demands. Infor offers deep industry-specific applications and suites, engineered for speed, and with an innovative user experience design that is simple, transparent, and elegant. Infor provides flexible deployment options that give customers a choice to run their businesses in the cloud, on-premises, or both.

To learn more about Infor, please visit www.infor.com.

Contact Information